TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma.
Li H, Lin Z, Zhuo J, Yang M, Shen W, Hu Z, Ding Y, Chen H, He C, Yang X, Dong S, Wei X, Sun B, Zheng S, Lang R, Lu D, Xu X.
Li H, et al. Among authors: he c.
Chin J Cancer Res. 2023 Feb 28;35(1):66-80. doi: 10.21147/j.issn.1000-9604.2023.01.07.
Chin J Cancer Res. 2023.
PMID: 36910852
Free PMC article.